of GSK in Research Triangle Park, North Carolina, and colleagues. No problems with safety or tolerability were identified, the group reported in Annals of the Rheumatic Diseases, leading them to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback